{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:36:26Z","timestamp":1793702186621,"version":"4.5.1"},"reference-count":36,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Diabetes Sci Technol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1177\/19322968241271304","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T10:01:09Z","timestamp":1725962469000},"page":"869-874","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["FDA Interoperability Designation\u2014Creating Options for People With Diabetes and Pump Companies: Regulatory, Technological, and Commercial Perspectives"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-6862","authenticated-orcid":false,"given":"David C.","family":"Klonoff","sequence":"first","affiliation":[{"name":"Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA"},{"name":"Diabetes Technology Society, Burlingame, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3067-1004","authenticated-orcid":false,"given":"Cindy N.","family":"Ho","sequence":"additional","affiliation":[{"name":"Diabetes Technology Society, Burlingame, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3054-3207","authenticated-orcid":false,"given":"Alessandra","family":"Ayers","sequence":"additional","affiliation":[{"name":"Diabetes Technology Society, Burlingame, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5549-1589","authenticated-orcid":false,"given":"Aiman","family":"Abdel-Malek","sequence":"additional","affiliation":[{"name":"Thirdwayv Inc., Irvine, CA, USA"},{"name":"Apex Medical Ai Inc., Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"Food and Drug Administration. FDA authorizes first interoperable automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-first-interoperable-automated-insulin-dosing-controller-designed-allow-more-choices. Published March 24 2020. Accessed July 15 2024."},{"key":"e_1_3_3_3_2","unstructured":"Kelm K. Re: SmartAdjust Technology 510(k) Premarket Notification of Intent to Market the Device. US FDA; 2022. www.accessdata.fda.gov\/cdrh_docs\/pdf20\/K203774.pdf. Accessed July 15 2024."},{"key":"e_1_3_3_4_2","unstructured":"Insulet Announces FDA 510(k) Clearance of the Omnipod\u00ae 5 App for iPhone. https:\/\/investors.insulet.com\/news\/news-details\/2023\/Insulet-Announces-FDA-510k-Clearance-of-the-Omnipod-5-App-for-iPhone\/default.aspx. Accessed July 15 2024."},{"key":"e_1_3_3_5_2","unstructured":"Federal Register. Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Interoperable Automated Glycemic Controller. https:\/\/www.federalregister.gov\/documents\/2022\/03\/14\/2022-05303\/medical-devices-clinical-chemistry-and-clinical-toxicology-devices-classification-of-the. Published March 14 2022. Accessed July 15 2024."},{"key":"e_1_3_3_6_2","unstructured":"Food and Drug Administration. FDA Roundup: January 24 2023.https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-roundup-january-24-2023. Published January 24 2023. Accessed July 15 2024."},{"key":"e_1_3_3_7_2","unstructured":"Sequel\u2019s twiistTM automated insulin delivery system receives FDA 510(k) Clearance. BioSpace. https:\/\/www.biospace.com\/sequel-s-twiist-automated-insulin-delivery-system-receives-fda-510-k-clearance. Published March 18 2024. Accessed July 15 2024."},{"key":"e_1_3_3_8_2","unstructured":"Balsam J. Re: iLet Dosing Decision Software 510(k) Premarket Notification of Intent to Market the Device. US Food and Drug Administration; 2023. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf23\/K232224.pdf. Accessed July 15 2024."},{"key":"e_1_3_3_9_2","unstructured":"Food and Drug Administration. FDA clears new insulin pump and algorithm-based software to support enhanced automatic insulin delivery. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-new-insulin-pump-and-algorithm-based-software-support-enhanced-automatic-insulin-delivery. Published May 22 2023. Accessed July 15 2024."},{"key":"e_1_3_3_10_2","unstructured":"mylife Loop offers new remote monitoring feature for parents.https:\/\/www.ypsomed.com\/en\/media\/details\/mylife-loop-offers-new-remote-monitoring-feature-for-parents.html. Published June 7 2023. Accessed July 15 2024."},{"key":"e_1_3_3_11_2","unstructured":"Omnipod\u00ae 5 automated insulin delivery system Omnipod. https:\/\/www.omnipod.com\/what-is-omnipod\/omnipod-5?utm_source=google&utm_medium=paid&utm_campaign=prso-aw&utm_content=pmax-brnd&ctoken=7012J000001gYaiQAE&utm_id=21364100800&ad_group_id=&gad_source=1. Accessed July 15 2024."},{"key":"e_1_3_3_12_2","unstructured":"Whooley SA. Sequel Med Tech\u2019s Unique Twiist AID System. Drug Delivery Business. https:\/\/www.drugdeliverybusiness.com\/look-at-sequel-med-tech-twiist\/. Published June 22 2024. Accessed July 22 2024."},{"key":"e_1_3_3_13_2","unstructured":"Tandem Diabetes. t:slim X2 Insulin Pump Type 1 diabetes insulin pump tandem diabetes care. https:\/\/www.tandemdiabetes.com\/products\/insulin-pumps\/t-slim-x2-insulin-pump. Accessed July 15 2024."},{"key":"e_1_3_3_14_2","unstructured":"Tandem secures FDA approval for t:slim X2 insulin pump with Control-IQ. NS Medical Devices. https:\/\/www.nsmedicaldevices.com\/news\/tandem-slim-x2-insulin-pump\/.Published December 16 2019. Accessed July 15 2024."},{"key":"e_1_3_3_15_2","unstructured":"Tandem Diabetes Care. Tandem Diabetes Care announces FDA approval and launch of t:slim X2 insulin pump with Dexcom G5 Mobile CGM Integration. https:\/\/investor.tandemdiabetes.com\/news-releases\/news-release-details\/tandem-diabetes-care-announces-fda-approval-and-launch-tslim-x2\/. Accessed July 15 2024."},{"key":"e_1_3_3_16_2","unstructured":"Tandem Diabetes Care. Tandem Diabetes Care launches Tandem Mobi the world\u2019s smallest durable automated insulin delivery system. https:\/\/investor.tandemdiabetes.com\/news-releases\/news-release-details\/tandem-diabetes-care-launches-tandem-mobi-worlds-smallest\/. Accessed July 15 2024."},{"key":"e_1_3_3_17_2","unstructured":"US Food and Drug Administration. 510(k) substantial equivalence determination decision summary: CamDiab Ltd. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/K232603.pdf. Accessed July 22 2024."},{"key":"e_1_3_3_18_2","unstructured":"Food and Drug Administration. FDA Roundup: May 24 2024. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-roundup-may-24-2024. Published May 24 2024. Accessed July 22 2024."},{"key":"e_1_3_3_19_2","unstructured":"Tidepool loop clearance. https:\/\/www.tidepool.org\/blog\/tidepool-loop-has-received-fda-clearance. Accessed July 22 2024."},{"key":"e_1_3_3_20_2","unstructured":"Tidepool loop traditional 510(k) premarket notification K203689. US Food and Drug Administration; 2023. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf20\/K203689.pdf. Accessed July 22 2024."},{"key":"e_1_3_3_21_2","unstructured":"Abbott MediaRoom. Tandem Diabetes Care\u2019s t:slim X2TM insulin pump is the first automated insulin delivery system to integrate with Abbott\u2019s New FreeStyle Libre\u00ae 2 Plus sensor. https:\/\/abbott.mediaroom.com\/2024-01-08-Tandem-Diabetes-Cares-t-slim-X2-Insulin-Pump-is-the-First-Automated-Insulin-Delivery-System-to-Integrate-with-Abbotts-New-FreeStyle-Libre-2-Plus-Sensor. Accessed July 22 2024."},{"key":"e_1_3_3_22_2","unstructured":"How accurate is my FreeStyle Libre 2 Plus sensor? FAQ.https:\/\/www.support.freestyle.abbott\/hc\/en-us\/articles\/21906401259665-How-accurate-is-my-FreeStyle-Libre-2-Plus-sensor. Accessed July 22 2024."},{"key":"e_1_3_3_23_2","unstructured":"Abbott MediaRoom. U.S.FDA Clears Abbott\u2019s FreeStyle Libre\u00ae 2 and FreeStyle Libre\u00ae 3 sensors for integration with automated insulin delivery systems. https:\/\/abbott.mediaroom.com\/2023-03-06-U-S-FDA-Clears-Abbotts-FreeStyle-Libre-R-2-and-FreeStyle-Libre-R-3-Sensors-for-Integration-with-Automated-Insulin-Delivery-Systems. Accessed July 22 2024."},{"key":"e_1_3_3_24_2","unstructured":"Business Wire Inc. Eversense\u00ae CGM system receives iCGM designation by the US FDA. https:\/\/www.businesswire.com\/news\/home\/20240429218967\/en\/. Published April 30 2024. Accessed July 22 2024."},{"key":"e_1_3_3_25_2","unstructured":"Dexcom G7 receives FDA clearance: The most accurate continuous glucose monitoring system cleared in the U.S. https:\/\/investors.dexcom.com\/news\/news-details\/2022\/Dexcom-G7-Receives-FDA-Clearance-The-Most-Accurate-Continuous-Glucose-Monitoring-System-Cleared-in-the-U.S\/default.aspx. Accessed July 22 2024."},{"key":"e_1_3_3_26_2","unstructured":"FDA-approved insulin pumps used for insulin pump therapy. https:\/\/lifesciencesintelligence.com\/features\/fda-approved-insulin-pumps-used-for-insulin-pump-therapy. Accessed July 15 2024."},{"key":"e_1_3_3_27_2","unstructured":"Food and Drug Administration. FDA approves first automated insulin delivery device for type 1 diabetes. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-automated-insulin-delivery-device-type-1-diabetes. Published March 24 2020. Accessed July 15 2024."},{"key":"e_1_3_3_28_2","unstructured":"Food and Drug Administration. MiniMed 780G System. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160017S091B.pdf. Accessed June 25 2024."},{"key":"e_1_3_3_29_2","unstructured":"FAQs\u2014MiniMedTM 770G system support medtronic. https:\/\/www.medtronicdiabetes.com\/customer-support\/minimed-770G-system-faqs. Published April 29 2021. Accessed July 15 2024."},{"key":"e_1_3_3_30_2","unstructured":"Integrated Diabetes Services. Medtronic 770G insulin pump pros cons. https:\/\/integrateddiabetes.com\/medtronic-770g-insulin-pump-pros-and-cons\/. Published December 30 2020. Accessed July 15 2024."},{"key":"e_1_3_3_31_2","unstructured":"Caposino P. Re: MiniMed 780G System Premarket Approval Application Supplement. US Food and Drug Administration; 2021. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160017S091A.pdf. Accessed July 15 2024."},{"key":"e_1_3_3_32_2","unstructured":"Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic\u2019s Insulin Delivery Devices. Abbott. https:\/\/abbott.mediaroom.com\/2024-08-07-Abbott-Enters-Global-Partnership-to-Connect-Its-World-Leading-Continuous-Glucose-Monitoring-System-with-Medtronics-Insulin-Delivery-Devices. August 7 2024. Accessed August 26 2024."},{"key":"e_1_3_3_33_2","unstructured":"Medtronic announces FDA approval of SimpleraTM CGM and global partnership with Abbott. Medtronic News. https:\/\/news.medtronic.com\/2024-08-07-Medtronic-announces-FDA-approval-of-Simplera-TM-CGM-and-global-partnership-with-Abbott. August 7 2024. Accessed August 26 2024."},{"key":"e_1_3_3_34_2","unstructured":"Food and Drug Administration. Center for Devices and Radiological Health. Premarket Notification 510(k). https:\/\/www.fda.gov\/medical-devices\/premarket-submissions-selecting-and-preparing-correct-submission\/premarket-notification-510k. Published December 5 2023. Accessed July 15 2024."},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00267-9"},{"key":"e_1_3_3_36_2","unstructured":"IEEE SA. IEEE Medical Device Cybersecurity Certification Program.https:\/\/standards.ieee.org\/products-programs\/icap\/programs\/medical-devices-cybersecurity\/. Accessed July 15 2024"},{"key":"e_1_3_3_37_2","unstructured":"Omnipod\u00ae 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes. Insulet. https:\/\/investors.insulet.com\/news\/news-details\/2024\/Omnipod-5-Automated-Insulin-Delivery-System-is-now-FDA-cleared-for-People-with-Type-2-Diabetes\/default.aspx. August 26 2024. Accessed August 26 2024."}],"container-title":["Journal of Diabetes Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968241271304","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19322968241271304","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968241271304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:17:10Z","timestamp":1777400230000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19322968241271304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1177\/19322968241271304"],"URL":"https:\/\/doi.org\/10.1177\/19322968241271304","relation":{},"ISSN":["1932-2968","1932-2968"],"issn-type":[{"value":"1932-2968","type":"print"},{"value":"1932-2968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]}}}